S&P 500   4,080.11 (+3.09%)
DOW   34,589.77 (+2.18%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
S&P 500   4,080.11 (+3.09%)
DOW   34,589.77 (+2.18%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
S&P 500   4,080.11 (+3.09%)
DOW   34,589.77 (+2.18%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
S&P 500   4,080.11 (+3.09%)
DOW   34,589.77 (+2.18%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
NASDAQ:TENX

Tenax Therapeutics - TENX Stock Forecast, Price & News

$0.15
+0.01 (+3.64%)
(As of 11/30/2022 05:19 PM ET)
Add
Compare
Today's Range
$0.13
$0.15
50-Day Range
$0.08
$0.19
52-Week Range
$0.08
$1.46
Volume
3.61 million shs
Average Volume
1.32 million shs
Market Capitalization
$6.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Tenax Therapeutics MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.88% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.30mentions of Tenax Therapeutics in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.40) to ($0.13) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

TENX stock logo

About Tenax Therapeutics (NASDAQ:TENX) Stock

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

Receive TENX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TENX Stock News Headlines

TENX: Agility Required to Unlock Considerable Upside
TENX: The Pressure’s On: Awaiting Phase 3 Start
Tenax Therapeutics Inc
Tenax Therapeutics Inc - Stock Quote TENX
TENX: 1Q:22 Financial and Operational Review
Tenax therapeutics announces $8M PIPE offering
TENX: 2021 Financial and Operational Review
See More Headlines
Receive TENX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TENX Company Calendar

Last Earnings
11/16/2021
Today
11/30/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TENX
Employees
8
Year Founded
1967

Profitability

Net Income
$-32,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.09 per share

Miscellaneous

Free Float
20,569,000
Market Cap
$6.62 million
Optionable
Not Optionable
Beta
1.96

Social Links


Key Executives

  • Mr. Christopher T. Giordano (Age 47)
    CEO, Pres & Director
    Comp: $279.44k
  • Mr. Eliot M. Lurier CPA (Age 64)
    Interim Chief Financial Officer
    Comp: $25.9k
  • Dr. Stuart Rich M.D. (Age 72)
    Chairman of Scientific Advisory Board, Chief Medical Officer & Director
    Comp: $415.53k
  • Ms. Nancy J. M. Hecox
    Exec. VP of Legal Affairs, Gen. Counsel & Corp. Sec.
  • Mr. Doug Randall
    Exec. VP of Commercial & Bus. Operations
  • Dr. Douglas Hay
    Sr. VP of Regulatory Affairs













TENX Stock - Frequently Asked Questions

How have TENX shares performed in 2022?

Tenax Therapeutics' stock was trading at $1.04 at the start of the year. Since then, TENX stock has decreased by 85.9% and is now trading at $0.1470.
View the best growth stocks for 2022 here
.

Are investors shorting Tenax Therapeutics?

Tenax Therapeutics saw a increase in short interest in November. As of November 15th, there was short interest totaling 391,200 shares, an increase of 96.3% from the October 31st total of 199,300 shares. Based on an average daily trading volume, of 4,100,000 shares, the short-interest ratio is currently 0.1 days.
View Tenax Therapeutics' Short Interest
.

When is Tenax Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our TENX earnings forecast
.

How were Tenax Therapeutics' earnings last quarter?

Tenax Therapeutics, Inc. (NASDAQ:TENX) issued its quarterly earnings data on Tuesday, November, 16th. The specialty pharmaceutical company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.02.

When did Tenax Therapeutics' stock split?

Shares of Tenax Therapeutics reverse split before market open on Monday, February 26th 2018. The 1-20 reverse split was announced on Friday, February 23rd 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 23rd 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Tenax Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tenax Therapeutics investors own include Sorrento Therapeutics (SRNE), AcelRx Pharmaceuticals (ACRX), Inovio Pharmaceuticals (INO), Idera Pharmaceuticals (IDRA), NVIDIA (NVDA), SCYNEXIS (SCYX), Verastem (VSTM), Bank of Hawaii (BOH), Gilead Sciences (GILD) and AVEO Pharmaceuticals (AVEO).

What is Tenax Therapeutics' stock symbol?

Tenax Therapeutics trades on the NASDAQ under the ticker symbol "TENX."

Who are Tenax Therapeutics' major shareholders?

Tenax Therapeutics' stock is owned by many different institutional and retail investors. Top institutional investors include Armistice Capital LLC (7.80%) and Vanguard Group Inc. (0.69%). Insiders that own company stock include Armistice Capital Master Fund, Armistice Capital, Llc and Ronald R Blanck.
View institutional ownership trends
.

How do I buy shares of Tenax Therapeutics?

Shares of TENX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tenax Therapeutics' stock price today?

One share of TENX stock can currently be purchased for approximately $0.15.

How much money does Tenax Therapeutics make?

Tenax Therapeutics (NASDAQ:TENX) has a market capitalization of $6.57 million.

How can I contact Tenax Therapeutics?

Tenax Therapeutics' mailing address is ONE COPLEY PARKWAY SUITE 490, MORRISVILLE NC, 27560. The official website for the company is www.tenaxthera.com. The specialty pharmaceutical company can be reached via phone at 919-855-2100, via email at jesse@sternir.com, or via fax at 919-855-2133.

This page (NASDAQ:TENX) was last updated on 11/30/2022 by MarketBeat.com Staff